Market Currents
Shares of YM Biosciences (YMI +16.1%) fall back to earth a bit after surging over 20% in AH and...
-
Tuesday, December 13, 2011, 1:32 PM ETShares of YM Biosciences (YMI +16.1%) fall back to earth a bit after surging over 20% in AH and premarket trading on positive results on testing of its CYT387 drug. Rodman & Renshaw's Reni Benjamin says the big takeaway from the data is that it meets the threshold of attracting interest from other companies looking to partner.
Other date
Latest Articles
